All News

Today we’re celebrating Jennifer Kristovich Craner, CPhT, at Inspira Medical Center in Mullica Hill, New Jersey.

Patients with cardiovascular disease who develop COVID-19 have a higher risk of mortality, according to a SCAI press release.

The 2 most common, recommended, and simplified treatments for HCV are glecaprevir/pibrentasvir (Mavyret) and sofosbuvir/velpatasvir (Epclusa).

Pharmacy adjudication systems vary among specialty pharmacies and many limitations still exist across most providers in the market.

New research has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.

With additional state action to remove testing restrictions, pharmacists will be able to continue their work to serve on the frontlines of health care during this pandemic.

Former NFL quarterback and Pro Football Hall of Fame member Jim Kelly announced as a keynote speaker for the 2020 NASP Annual Meeting & Expo.

Two case studies have highlighted the use of tele-diabetes to manage new-onset type 1 diabetes (T1D) cases in an adult and an infant during the coronavirus disease 2019 (COVID-19) pandemic.

In this episode of OnScript with NHA, Jeremy Sasser and Jessica Langley speak to Dr. Ken Thai. Dr. Thai is the current president of the California Pharmacist’s Association, and CEO of 986 Pharmacy in California.

Pharmacy managers must be especially adept at negotiating with various stakeholders, and pass on their negotiating skills to other pharmacy employees.

Leaders with a clear sense of what they are fighting for, and why, are better able to convey their vision to future followers and help others recognize the importance of their mission.

A new study indicates that treatment with hydroxychloroquine increases overall mortality in patients hospitalized with COVID-19.

Sacituzumab govitecan-hziy is the first antibody-drug conjugates approved by the FDA specifically for relapsed or refractory metastatic triple-negative breast cancer (TNBC).

Implementation of adherence programs can be effective in improving outcomes for patients and reduce costs both at the patient and systemic level.